Loading...

TYRA TYRA BIOSCIENCES INC Management Changes 8-K Filing

TYR

TYR

TYRA BIOSCIENCES INC

(TYRA)

2023 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Financial Results

Director Resignation

Equity Exchange

Financial Results Announcement

Annual Meeting and Liabilit...

Financial Results Announcement

Appointment of Directors

Earnings Reports

Private Placement

FDA Designation for TYRA-30...

Initiation of SURF201 Phase...

Earnings Reports

Amended and Restated Bylaws

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Incentive Plan Adoption and...

External Links:

Tyra Biosciences, Inc. announced the adoption of an annual incentive plan for employees and the expansion of development of TYRA-300 into achondroplasia based on positive preclinical results.

AI Assistant

TYRA BIOSCIENCES INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.